This invention relates to the field of
materials science and technology, and discloses the application of zwitterionic
polymer injectable hydrogels as vitreous substitutes. Zwitterionic monomers selected from CBUIA, CBUTA, CBOH, CBMA, or MPC are dissolved in an aqueous phase, and
polymerization is initiated by an initiator to obtain a hydrogel. After swelling equilibrium, the zwitterionic
polymer injectable hydrogel is obtained. This invention uses initiator-initiated free
radical polymerization of monomers and prepares physically cross-linked pure zwitterionic hydrogels through multi-
hydrogen bond interactions or chain entanglement. The pure zwitterionic hydrogel with injectable properties is prepared through swelling equilibrium. It exhibits good
biocompatibility, which is beneficial for improving the affinity of this zwitterionic
polymer-based hydrogel vitreous substitute to the
vitreous cavity, reducing adverse reactions after implantation. Furthermore, the preparation method is simple and the conditions are mild, making it more suitable for large-scale promotion and use as a vitreous substitute in
ocular surgery, and it exhibits excellent
biofouling resistance.